Research Articles | Page 98 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the Nort Aug 2020 Pediatric Blood & Cancer aplastic anemia, pediatric
Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium Aug 2020 Pediatric Blood & Cancer aplastic anemia, myelodysplastic syndromes (MDS), pediatric
Cotransplantation of allogeneic mesenchymal and hematopoietic stem cells in children with aplastic anemia May 2012 Pediatrics aplastic anemia
Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia: a multicentre study Jul 2014 PLoS One paroxysmal nocturnal hemoglobinuria (PNH)
Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome Mar 2017 PLoS One myelodysplastic syndromes (MDS)
Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria. Sep 2020 PloS One paroxysmal nocturnal hemoglobinuria (PNH)
Reduced intensity conditioning, combined transplantation of haploidentical hematopoietic stem cells and mesenchymal stem cells in patients with severe aplastic anemia Mar 2014 PLoS One aplastic anemia
Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis Feb 2017 PLoS One myelodysplastic syndromes (MDS)
Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis Nov 2016 PLoS One myelodysplastic syndromes (MDS)
The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes Jan 2012 PLoS One myelodysplastic syndromes (MDS)
Share with addtoany.com.